773 filings
Page 11 of 39
DEFA14A
CRVO
CervoMed Inc
20 May 21
Additional proxy soliciting materials
4:21pm
4
Jane H Hollingsworth
17 May 21
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
4:27pm
8-K
CRVO
CervoMed Inc
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am
10-Q
2021 Q1
CRVO
CervoMed Inc
Quarterly report
7 May 21
4:45pm
8-K
CRVO
CervoMed Inc
7 May 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
DEF 14A
CRVO
CervoMed Inc
Definitive proxy
30 Apr 21
12:00am
8-K
CRVO
CervoMed Inc
25 Mar 21
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
5:20pm
8-K
CRVO
CervoMed Inc
18 Mar 21
Regulation FD Disclosure
4:14pm
8-K
CRVO
CervoMed Inc
17 Mar 21
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
4:36pm
10-K
2020 FY
CRVO
CervoMed Inc
Annual report
16 Mar 21
9:58pm
8-K
CRVO
CervoMed Inc
8 Mar 21
Regulation FD Disclosure
4:10pm
4
Cobuzzi Robert Joseph Jr.
4 Mar 21
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
7:33pm
4
William Robert Elder
4 Mar 21
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:33pm
4
Christopher D Galloway
4 Mar 21
Diffusion Pharmaceuticals / CHRISTOPHER D GALLOWAY ownership change
7:32pm
4
William Karl Hornung
4 Mar 21
Diffusion Pharmaceuticals / William Karl Hornung ownership change
7:32pm
8-K
CRVO
CervoMed Inc
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
CRVO
CervoMed Inc
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
CRVO
CervoMed Inc
16 Feb 21
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
8:10am
8-K
CRVO
CervoMed Inc
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
FWP
CRVO
CervoMed Inc
11 Feb 21
Free writing prospectus
9:56pm